Ventyx Biosciences, Inc. - VTYX
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G/A | TANG CAPITAL MANAGEMENT, LLC | 0.0% | 0 | View |
| May 15, 2026 | SCHEDULE 13G/A | KEVIN TANG | 0.0% | 0 | View |
| May 15, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS, LP | 0.0% | 0 | View |
| May 15, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS INTERNATIONAL, LP | 0.0% | 0 | View |
| May 15, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS III, INC | 0.0% | 0 | View |
| May 15, 2026 | SCHEDULE 13G/A | TANG CAPITAL PARTNERS IV, INC | 0.0% | 0 | View |
| May 14, 2026 | SCHEDULE 13G/A | Affinity Asset Advisors, LLC | 0.0% | 0 | View |
| May 14, 2026 | SCHEDULE 13G/A | Michael Cho | 0.0% | 0 | View |
| May 14, 2026 | SCHEDULE 13G/A | Glazer Capital, LLC | 0.0% | 0 | View |
| May 14, 2026 | SCHEDULE 13G/A | Paul J. Glazer | 0.0% | 0 | View |
| Mar 05, 2026 | SCHEDULE 13D/A | — | — | — | View |
| Feb 19, 2026 | SCHEDULE 13G | Glazer Capital, LLC | 6.23% | 4,446,004 | View |
| Feb 19, 2026 | SCHEDULE 13G | Paul J. Glazer | 6.23% | 4,446,004 | View |
| Feb 06, 2026 | SCHEDULE 13G/A | Morgan Stanley | 0.3% | 237,358 | View |
| Feb 05, 2026 | SCHEDULE 13G | Morgan Stanley | 6.0% | 4,289,915 | View |
| Jan 29, 2026 | SCHEDULE 13G/A | Affinity Asset Advisors, LLC | 9.0% | 6,465,041 | View |
| Jan 29, 2026 | SCHEDULE 13G/A | Michael Cho | 9.0% | 6,465,041 | View |
| Jan 09, 2026 | SCHEDULE 13D/A | — | — | 1,807,664 | View |
| Jan 09, 2026 | SCHEDULE 13D/A | — | — | 71,358,638 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.